Literature DB >> 2999320

Inhibition of herpes simplex virus type 1-induced interferon synthesis by monoclonal antibodies against viral glycoprotein D and by lysosomotropic drugs.

P Lebon.   

Abstract

Components of herpes simplex virus remained bound to the diploid cell membrane after nucleocapsid penetration into the cytosol. These components enabled the infected cells to induce interferon-alpha (IFN-alpha) in peripheral blood mononuclear cells even when the infected cells were fixed by glutaraldehyde. Monoclonal antibodies directed against the major viral glycoprotein D could neutralize their IFN-alpha-inducing capacity. Thus, the process of IFN induction does not require uptake and penetration of the inducer into the effector cells. The process was, however, sensitive to lysosomotropic drugs. These data suggest that a membrane receptor is involved in the IFN-alpha induction mechanism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2999320     DOI: 10.1099/0022-1317-66-12-2781

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  28 in total

1.  Interferon gamma in acute and subacute encephalitis.

Authors:  P Lebon; B Boutin; O Dulac; G Ponsot; M Arthuis
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-02

2.  Induction of alpha interferon by transmissible gastroenteritis coronavirus: role of transmembrane glycoprotein E1.

Authors:  B Charley; H Laude
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

Review 3.  The role of type I interferon production by dendritic cells in host defense.

Authors:  P Fitzgerald-Bocarsly; D Feng
Journal:  Biochimie       Date:  2007-05-08       Impact factor: 4.079

4.  Native and recombinant herpes simplex virus type 1 envelope proteins induce human immune T-lymphocyte responses.

Authors:  J W Torseth; G H Cohen; R J Eisenberg; P W Berman; L A Lasky; C P Cerini; C J Heilman; S Kerwar; T C Merigan
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

5.  Activation of interferon response factor-3 in human cells infected with herpes simplex virus type 1 or human cytomegalovirus.

Authors:  C M Preston; A N Harman; M J Nicholl
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  Antiviral activity of Engystol® and Gripp-Heel®: an in-vitro assessment.

Authors:  Kerstin Roeska; Bernd Seilheimer
Journal:  J Immune Based Ther Vaccines       Date:  2010-11-16

7.  Chloroquine modulates HIV-1-induced plasmacytoid dendritic cell alpha interferon: implication for T-cell activation.

Authors:  Jeffrey A Martinson; Carlos J Montoya; Xiomara Usuga; Rollie Ronquillo; Alan L Landay; Seema N Desai
Journal:  Antimicrob Agents Chemother       Date:  2009-11-30       Impact factor: 5.191

Review 8.  New roles for the major human 3'-5' exonuclease TREX1 in human disease.

Authors:  David Kavanagh; Dirk Spitzer; Parul H Kothari; Aisha Shaikh; M Kathryn Liszewski; Anna Richards; John P Atkinson
Journal:  Cell Cycle       Date:  2008-06-16       Impact factor: 4.534

Review 9.  The innate immune system in SLE: type I interferons and dendritic cells.

Authors:  L Rönnblom; V Pascual
Journal:  Lupus       Date:  2008-05       Impact factor: 2.911

10.  Single amino acid changes in the viral glycoprotein M affect induction of alpha interferon by the coronavirus transmissible gastroenteritis virus.

Authors:  H Laude; J Gelfi; L Lavenant; B Charley
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.